Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2025-06-15 Board/Management Inform…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Letter to Shareholders 2 pages 98.8KB
Board/Management Information Classification · 95% confidence The document is an announcement regarding the Chairman seeking re-election and director nominations for the upcoming Annual Shareholders' Meeting (ASM). It discusses board continuity, director rotation, and nomination procedures. There is no financial data, earnings information, or detailed report content. The document is focused on board and management information, specifically about director nominations and re-election. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is clearly an announcement rather than a full report or meeting materials, so it is not AGM Information or Proxy Solicitation.
2025-06-15 English
PEB – Waiver from NZX Listing Rule 4.19.1
Regulatory Filings Classification · 95% confidence The document is a regulatory decision from NZ RegCo granting a waiver to Pacific Edge Limited (PEB) from NZX Listing Rule 4.19.1 related to the allotment timing of shares under a Placement. It discusses the background, conditions, and reasons for the waiver, referencing the NZX Listing Rules and shareholder meeting approvals. The document is not a financial report, earnings release, or management discussion but a regulatory announcement about a waiver related to capital raising and share allotment timing. It does not contain financial statements or detailed financial analysis but is a formal regulatory filing about compliance with listing rules and shareholder approvals. Therefore, it fits best under Regulatory Filings (RNS).
2025-06-12 English
PEB – Trading to resume at market open
Regulatory Filings Classification · 95% confidence The document is a short memorandum from NZX Limited notifying market participants that trading in Pacific Edge Limited's equity securities will resume. It references a market announcement but does not contain financial data, report content, or detailed information about the company’s financials or governance. The document is brief (608 characters) and serves as a trading resumption notice rather than a report or detailed announcement. This fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices that do not fit other specific categories.
2025-06-02 English
Pacific Edge Placement Upsized to NZ$16 Million
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 3 June 2025 from Pacific Edge regarding the successful raising of NZ$16 million through a placement of new ordinary shares, with details about the placement, pricing, shareholder approval requirements, and a planned Share Purchase Plan (SPP). It discusses capital raising activities, shareholder meetings for approval, and regulatory approvals. There is no detailed financial report or analysis, no earnings data, no management discussion of financial results, and no mention of an attached or forthcoming report. The content focuses on financing activities and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length (5827 characters) supports it being a full announcement rather than a brief notice or report publication announcement. Confidence is high given the clear focus on equity raising and placement details.
2025-06-02 English
Pacific Edge Placement Upsized to NZ$16 Million 2 pages 102.9KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 3 June 2025 from Pacific Edge regarding the successful raising of NZ$16 million through a placement of new ordinary shares, with details about the placement, pricing, shareholder approval requirements, and a planned Share Purchase Plan (SPP). It discusses capital raising activities, shareholder meetings for approval, and regulatory approvals related to the equity raise. There are no financial statements or detailed financial performance data presented, nor is this a transcript, report, or presentation. The content focuses on financing activities and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is 5827 characters, which is sufficient to be a full announcement rather than a brief notice or report publication announcement.
2025-06-02 English
Pacific Edge Limited (“PEB”) – Trading Halt of Securities
Regulatory Filings Classification · 95% confidence The document is a memorandum from NZX Limited announcing a trading halt of securities for Pacific Edge Limited. It mentions the approval of a trading halt application and that trading was halted at pre-market open. There is no financial data, report, or detailed analysis present. The document is an announcement related to trading status rather than a financial report or regulatory filing about company performance or governance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-05-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.